|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 88, 965-971, Copyright © 1984 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
GS Kobinia, PJ LaRaia, MB Peterson, MN D'Ambra, WD Watkins, WG Austen and MJ Buckley
We have investigated the response of systemic and myocardial prostacyclin
metabolism to cardiopulmonary bypass and 30 minutes of hypothermic (22
degrees C), hyperkalemic (25 mEq K+) surgical cardioplegia. Thirteen adult
mongrel dogs of either sex (range 21 to 36 kg) underwent sterile
cardiopulmonary bypass without donor blood. Prostacyclin levels were
obtained after cannulation, 20 minutes after onset of partial bypass, and 5
seconds after the onset of cardioplegia 1 (CP-1) and cardioplegia 2 (CP-2,
30 minutes later). Samples were drawn from the thoracic aorta, the aortic
root below cross-clamping, and the coronary sinus. The stable metabolite of
prostacyclin, 6-keto- PGF1 alpha was measured by double-antibody
radioimmunoassay (pg/ml; values +/- standard error of the mean). We found
that the onset of partial bypass is associated with significant increase in
the systemic production of 6-keto-PGF1 alpha (122 +/- 33 versus 518 +/-
187; p less than 0.05), which persists throughout the experiment. A small
but significant positive cardiac gradient of 6-keto-PGF1 alpha is found
after cannulation (aortic root 122 +/- 33, coronary sinus 202 +/- 57, p
less than 0.05). This gradient is more pronounced during partial bypass
(aortic root 518 +/- 187, coronary sinus 686 +/- 186 p less than 0.05),
when significant cardiac lactate extraction (p less than 0.005) is
observed. After cross-clamping, a significantly increased gradient of 6-
keto-PGF1 alpha is found during CP-1 (aortic root 74 +/- 10, coronary sinus
264 +/- 46, p less than 0.05 versus cannulation) in the presence of
significant cardiac lactate production (p less than 0.005). A further
significant increase in 6-keto-PGF1 alpha production is noted during the
CP-2 infusion (aortic root 73 +/- 10, coronary sinus 483 +/- 83; p less
than 0.01 versus CP-1), which is inversely related to cardiac oxygen uptake
and endocardial/epicardial flow ratio. Our data demonstrate significant
production of prostacyclin in the systemic and cardiac circulations during
cardiopulmonary bypass and surgical cardioplegia. They further indicate
that both ischemic and nonischemic stimuli regulate prostacyclin metabolism
during cardiopulmonary bypass.
ARTICLES
Cardiac prostacyclin kinetics during cardiopulmonary bypass
This article has been cited by other articles:
![]() |
H. P. Singh, E. T. Coleman, M. Hargrove, S. E. Barrow, M. B. Murphy, and T. Aherne Prostacyclin and Thromboxane Levels in Pleural Space Fluid During Cardiopulmonary Bypass Ann. Thorac. Surg., March 1, 1995; 59(3): 647 - 650. [Abstract] [Full Text] |
||||
![]() |
E. S. Yee and W.-R. Hsieh Modification of Myocardial Reperfusion by Exogenous Prostacyclin Vascular and Endovascular Surgery, October 1, 1992; 26(8): 605 - 611. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |